Solventum Co. (NYSE:SOLV) Given Average Rating of “Hold” by Brokerages

Shares of Solventum Co. (NYSE:SOLV) have earned an average recommendation of “Hold” from the eleven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $79.86.

A number of research analysts have issued reports on the stock. Bank of America upped their target price on shares of Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 26th. Morgan Stanley increased their price objective on shares of Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a report on Wednesday, March 5th. Wells Fargo & Company lifted their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. The Goldman Sachs Group upped their target price on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research report on Monday, March 3rd. Finally, Mizuho raised their price target on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd.

Solventum Price Performance

Solventum stock opened at $74.87 on Wednesday. The business’s 50-day simple moving average is $75.38 and its 200 day simple moving average is $71.73. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The stock has a market cap of $12.95 billion and a price-to-earnings ratio of 27.23. Solventum has a 12-month low of $47.16 and a 12-month high of $85.92.

Hedge Funds Weigh In On Solventum

Hedge funds and other institutional investors have recently made changes to their positions in the company. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Solventum during the 3rd quarter worth $231,000. Intech Investment Management LLC acquired a new stake in shares of Solventum during the third quarter worth about $317,000. Landscape Capital Management L.L.C. bought a new position in shares of Solventum during the 3rd quarter valued at about $227,000. Cerity Partners LLC grew its position in shares of Solventum by 27.4% in the 3rd quarter. Cerity Partners LLC now owns 52,719 shares of the company’s stock valued at $3,676,000 after purchasing an additional 11,337 shares during the period. Finally, Swedbank AB increased its stake in Solventum by 20.3% during the 3rd quarter. Swedbank AB now owns 107,197 shares of the company’s stock worth $7,474,000 after purchasing an additional 18,108 shares in the last quarter.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.